The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
Open accessAbstract
Systemic arterial hypertension (referred to as hypertension herein) is a major risk factor of mortality worldwide, and its importance is further emphasized in the context of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection referred to as COVID-19. Patients with severe COVID-19 infections commonly are older and have a history of hypertension. Almost 75% of patients who have died in the pandemic in Italy had hypertension. This raised multiple questions regarding a more severe course of COVID-19 in relation to hypertension itself as well as its treatment with renin–angiotensin system (RAS) blockers, e.g. angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). We provide a critical review on the relationship of hypertension, RAS, and risk of lung injury. We demonstrate lack of sound evidence that hypertension per se is an independent risk factor for COVID-19. Interestingly, ACEIs and ARBs may be associated with lower incidence and/or improved outcome in patients with lower respiratory tract infections. We also review in detail the molecular mechanisms linking the RAS to lung damage and the potential clinical impact of treatment with RAS blockers in patients with COVID-19 and a high cardiovascular and renal risk. This is related to the role of angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 entry into cells, and expression of ACE2 in the lung, cardiovascular system, kidney, and other tissues. In summary, a critical review of available evidence does not support a deleterious effect of RAS blockers in COVID-19 infections. Therefore, there is currently no reason to discontinue RAS blockers in stable patients facing the COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationZhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
COVID-19 and Italy: what next?
Remuzzi, A., & Remuzzi, G. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30627-9 · Cited by 3,119
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Self-citationZhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Covid-19 — Navigating the Uncharted
Fauci, A. S., Lane, H. C., & Redfield, R. R. (2020) · New England Journal of Medicine · doi:10.1056/nejme2002387 · Cited by 1,969
Potential Effects of Coronaviruses on the Cardiovascular System: A Review
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1286 · Cited by 1,793
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Self-citationStatus of Hypertension in China: Results From the China Hypertension Survey, 2012–2015
Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., Shao, L., Tian, Y., Dong, Y., Zheng, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032380 · Cited by 1,698
Self-citationFerrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Viral load of SARS-CoV-2 in clinical samples.
Pan, Y., Zhang, D., Yang, P., Poon, L. L. M., & Wang, Q. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30113-4 · Cited by 1,562 · cited 1×
“has been reported to be much higher as compared with faecal samples and thus may contribute to the preferential transmission of the virus in the respiratory tract.(87) Taken together, the respiratory tract appears as”
ResultHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D., Coca, A., De Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001961 · Cited by 882
Self-citationHeurich, A., Hofmann-Winkler, H., Gierer, S., Liepold, T., Jahn, O., & Pöhlmann, S. (2014) · Journal of Virology · doi:10.1128/jvi.02202-13 · Cited by 881
Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., Huang, X., Ning, G., & Wang, W. (2020) · Cell Discovery · doi:10.1038/s41421-020-0147-1 · Cited by 865
Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?
Yeo, C., Kaushal, S., & Yeo, D. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30048-0 · Cited by 817
Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010) · Journal of Virology · doi:10.1128/jvi.01542-10 · Cited by 778
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D., Coca, A., De Simone, G., Dominiczak, A., et al. (2018) · Blood Pressure · doi:10.1080/08037051.2018.1527177 · Cited by 710
Self-citationRuilope, L. M., Dukat, A., Böhm, M., Lacourcière, Y., Gong, J., & Lefkowitz, M. P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61966-8 · Cited by 599
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Danser, A. H. J., Epstein, M., & Batlle, D. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15082 · Cited by 457
Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China
Porcheddu, R., Serra, C., Kelvin, D., Kelvin, N., & Rubino, S. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12600 · Cited by 434
Immune mechanisms of hypertension
Drummond, G. R., Vinh, A., Guzik, T. J., & Sobey, C. G. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0160-5 · Cited by 428
Self-citationMyocardial infarction increases ACE2 expression in rat and humans
Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi114 · Cited by 423
Corrales-Medina, V. F., Musher, D. M., Wells, G. A., Chirinos, J. A., Chen, L., & Fine, M. J. (2012) · Circulation · doi:10.1161/circulationaha.111.040766 · Cited by 414
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4594 · Cited by 401
Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., Pöhlmann, S., & Soilleux, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035876 · Cited by 398
Risk factors for pneumonia in the elderly
Koivula, I., Sten, M., & Makela, P. H. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90060-4 · Cited by 362
Sims, A. C., Baric, R. S., Yount, B., Burkett, S. E., Collins, P. L., & Pickles, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15511-15524.2005 · Cited by 349
Czesnikiewicz-Guzik, M., Osmenda, G., Siedlinski, M., Nosalski, R., Pelka, P., Nowakowski, D., Wilk, G., Mikolajczyk, T. P., Schramm-Luc, A., Furtak, A., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz646 · Cited by 346
Self-citationArendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in mice
Imai, Y., Kuba, K., & Penninger, J. M. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040048 · Cited by 334
Sodhi, C. P., Wohlford-Lenane, C., Yamaguchi, Y., Prindle, T., Fulton, W. B., Wang, S., McCray, P. B., Chappell, M., Hackam, D. J., & Jia, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00498.2016 · Cited by 333
Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Vuille-dit-Bille, R. N., Camargo, S. M., Emmenegger, L., Sasse, T., Kummer, E., Jando, J., Hamie, Q. M., Meier, C. F., Hunziker, S., Forras-Kaufmann, Z., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1889-6 · Cited by 312
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
Esler, M., & Esler, D. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002450 · Cited by 296
Youn, J.-C., Yu, H. T., Lim, B. J., Koh, M. J., Lee, J., Chang, D.-Y., Choi, Y. S., Lee, S.-H., Kang, S.-M., Jang, Y., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00689 · Cited by 284
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
Yang, P., Gu, H., Zhao, Z., Wang, W., Cao, B., Lai, C., Yang, X., Zhang, L., Duan, Y., Zhang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07027 · Cited by 283
[18] Peptidyl dipeptidase A: Angiotensin I-converting enzyme
Corvol, P., Williams, T. A., & Soubrier, F. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)48020-x · Cited by 277
New approaches in the treatment of hypertension
Oparil, S., & Schmieder, R. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.303603 · Cited by 276 · cited 3×
“[50] [51] [52] [53] [54] The RAS is, however, a much more complex system with additional components and sites of action that influence not only blood pressure homeostasis and cardiovascular function, but also the function and injury of several organs [50] [51] [52] 54 including the lung.”
BackgroundOcaranza, M. P., Godoy, I., Jalil, J. E., Varas, M., Collantes, P., Pinto, M., Roman, M., Ramirez, C., Copaja, M., Diaz-Araya, G., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000237862.94083.45 · Cited by 273
Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans
Itani, H. A., McMaster, W. G., Saleh, M. A., Nazarewicz, R. R., Mikolajczyk, T. P., Kaszuba, A. M., Konior, A., Prejbisz, A., Januszewicz, A., Norlander, A. E., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07237 · Cited by 271
Self-citationFuruhashi, M., Moniwa, N., Mita, T., Fuseya, T., Ishimura, S., Ohno, K., Shibata, S., Tanaka, M., Watanabe, Y., Akasaka, H., et al. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu086 · Cited by 263
Ferrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Caldeira, D., Alarcao, J., Vaz-Carneiro, A., & Costa, J. (2012) · BMJ · doi:10.1136/bmj.e4260 · Cited by 246
Q&A: The novel coronavirus outbreak causing COVID-19
Fisher, D., & Heymann, D. (2020) · BMC Medicine · doi:10.1186/s12916-020-01533-w · Cited by 226
Gutiérrez, F., Masiá, M., Mirete, C., Soldán, B., Carlos Rodríguez, J., Padilla, S., Hernández, I., Royo, G., & Martin-Hidalgo, A. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.006 · Cited by 224
Ye, R., & Liu, Z. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104350 · Cited by 205
Igase, M., Strawn, W. B., Gallagher, P. E., Geary, R. L., & Ferrario, C. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2005 · Cited by 203
White Blood Cells and Blood Pressure: A Mendelian Randomization Study
Siedlinski, M., Jozefczuk, E., Xu, X., Teumer, A., Evangelou, E., Schnabel, R. B., Welsh, P., Maffia, P., Erdmann, J., Tomaszewski, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045102 · Cited by 201
Self-citationKeidar, S., Gamliel-Lazarovich, A., Kaplan, M., Pavlotzky, E., Hamoud, S., Hayek, T., Karry, R., & Abassi, Z. (2005) · Circulation Research · doi:10.1161/01.res.0000187500.24964.7a · Cited by 193
Loperena, R., Van Beusecum, J. P., Itani, H. A., Engel, N., Laroumanie, F., Xiao, L., Elijovich, F., Laffer, C. L., Gnecco, J. S., Noonan, J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy112 · Cited by 187
Self-citationTargeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases
Tan, W. S. D., Liao, W., Zhou, S., Mei, D., & Wong, W.-S. F. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.12.002 · Cited by 182
Novel RAAS agonists and antagonists: clinical applications and controversies
Romero, C. A., Orías, M., & Weir, M. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.6 · Cited by 150
Agata, J., Ura, N., Yoshida, H., Shinshi, Y., Sasaki, H., Hyakkoku, M., Taniguchi, S., & Shimamoto, K. (2006) · Hypertension Research · doi:10.1291/hypres.29.865 · Cited by 132
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Ferrario, C. M., & Mullick, A. E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.020 · Cited by 132
Jessup, J. A., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Chappell, M. C., & Ferrario, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00061.2006 · Cited by 128
Cai, G. (2020) · medRxiv · doi:10.1101/2020.02.05.20020107 · Cited by 128
Sukumaran, V., Veeraveedu, P. T., Gurusamy, N., Yamaguchi, K., Lakshmanan, A. P., Ma, M., Suzuki, K., Kodama, M., & Watanabe, K. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1077 · Cited by 126
Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia
Henry, C. H., Zaizafoun, M., Stock, E. M., Ghamande, S. A., Arroliga, A. C., & White, H. D. (2018) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2018.1499293 · Cited by 124
Schouten, L. R. A., van Kaam, A. H., Kohse, F., Veltkamp, F., Bos, L. D. J., de Beer, F. M., van Hooijdonk, R. T. M., Horn, J., Straat, M., Witteveen, E., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0529-4 · Cited by 123
Whaley‐Connell, A. T., Chowdhury, N. A., Hayden, M. R., Stump, C. S., Habibi, J., Wiedmeyer, C. E., Gallagher, P. E., Tallant, E. A., Cooper, S. A., Link, C. D., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00167.2006 · Cited by 121
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
Chou, C., Hung, C., Liao, C., Wei, L., Chen, C., Shun, C., Wen, W.-F., Wan, C., Wu, X.-M., Chang, Y., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy013 · Cited by 116
Ketelhuth, D. F. J., Lutgens, E., Bäck, M., Binder, C. J., den Bossche, J. V., Daniel, C., Dumitriu, I. E., Hoefer, I. E., Libby, P., O'Neill, L. A. J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz166 · Cited by 106
Li, Y., Zeng, Z., Li, Y., Huang, W.-F., Zhou, M. S., Zhang, X., & Jiang, W. (2015) · Shock · doi:10.1097/shk.0000000000000302 · Cited by 99
Pharmacologic modulation of ACE2 expression
Soler, M. J., Barrios, C., Oliva, R., & BATLLE, D. C. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0076-0 · Cited by 88
Hamming, I., van Goor, H., Turner, A. J., Rushworth, C. A., Michaud, A., Corvol, P. L., & Navis, G. J. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041855 · Cited by 87
Karram, T., Abbasi, A. H., Keidar, S., Golomb, E., Hochberg, I., Winaver, J. M., Hoffman, A., & Abassi, Z. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01186.2004 · Cited by 84
TAKEDA, Y., ZHU, A., YONEDA, T., Usukura, M., TAKATA, H., & YAMAGISHI, M. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.05.008 · Cited by 79
Tocci, G., Nati, G., Cricelli, C. A., Parretti, D., Lapi, F., Ferrucci, A., Borghi, C., & Volpe, M. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.71 · Cited by 72
Liu, L., Qiu, H., Yang, Y., Wang, L., Ding, H.-M., & Li, H.-P. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.09.019 · Cited by 71
Stopping RAS Inhibitors to Minimize AKI: More Harm than Good?
Tomson, C., & Tomlinson, L. A. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14021118 · Cited by 69
Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease
Ingelfinger, J. R. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831b70ad · Cited by 67
Boskabadi, S. J., Askari, V. R., Hosseini, M., & Boskabady, M. H. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0535-4 · Cited by 50
Fattah, C., Nather, K., McCarroll, C. S., Hortigon-Vinagre, M. P., Zamora, V., Flores‐Muñoz, M., McArthur, L., Zentilin, L., Giacca, M., Touyz, R. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.946 · Cited by 47
Perrotta, M., Lori, A., Carnevale, L., Fardella, S., Cifelli, G., Iacobucci, R., Mastroiacovo, F., Iodice, D., Pallante, F., Storto, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy001 · Cited by 45
Ketelhuth, D. F. J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz067 · Cited by 44
Sukumaran, V., Veeraveedu, P. T., Lakshmanan, A. P., Gurusamy, N., Yamaguchi, K., Ma, M., Suzuki, K., Kodama, M., & Watanabe, K. (2012) · Free Radical Research · doi:10.3109/10715762.2012.684878 · Cited by 34
Renin Angiotensin system-modifying therapies are associated with improved pulmonary health
Soto, M., Bang, S. I., McCombs, J., & Rodgers, K. E. (2017) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-017-0044-1 · Cited by 31
Stoll, D., Yokota, R., Aragão, D. S., & Casarini, D. E. (2019) · Physiological Reports · doi:10.14814/phy2.14105 · Cited by 31
Deng, W., Deng, Y. W., Deng, J., Wang, D., & Zhang, T. (2015) · PubMed Central · Cited by 29
Abe, M., Oikawa, O., Okada, K., & Soma, M. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320314551443 · Cited by 28
Shah, S. R., McArthur, E., Farag, A., Nartey, M., Fleet, J. L., Knoll, G. A., Kim, S. J., Garg, A. X., & Jain, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110165 · Cited by 27
Gilliam‐Davis, S., Gallagher, P. E., Payne, V. S., Kasper, S. O., Tommasi, E. N., Westwood, B. M., Robbins, M. E. C., Chappell, M. C., & Diz, D. I. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00167.2010 · Cited by 23
Biobanking and cryopreservation of human lung explants for omic analysis
Chu, S. G., Poli, S., Sakairi, Y., Kelly, R. S., Chase, R., Konishi, K., Blau, A., Tsai, E. A., Tsoyi, K., Padera, R. F., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01635-2018 · Cited by 18
Kang, J., Kao, L., Lin, H., Wang, T.-J., & Yang, T.-Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199981 · Cited by 15
A structural network associated with the kallikrein-kinin and renin-angiotensin systems
Stoka, V., & Türk, V. (2010) · Biological Chemistry · doi:10.1515/bc.2010.046 · Cited by 12
Carnevale, D., & Wenzel, P. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy148 · Cited by 12
Choi, J., Jang, J., An, Y., & Park, S. K. (2018) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.18.212 · Cited by 7
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationZhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,521
Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D’Acquisto, F., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa106 · Cited by 1,440
Self-citationRenin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,073
Systemic racism, chronic health inequities, and COVID‐19: A syndemic in the making?
Gravlee, C. C. (2020) · American Journal of Human Biology · doi:10.1002/ajhb.23482 · Cited by 374
Metadata
- Authors
- Kreutz, R., Algharably, E. A. E.-H., Azizi, M., Dobrowolski, P., Guzik, T., Januszewicz, A., Persu, A., Prejbisz, A., Riemer, T. G., Wang, J.-G., & Burnier, M.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-15
- Volume
- 116
- Issue
- 10
- Pages
- 1688-1699
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W3016259848
- Cited by
- 357
- References
- 118
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.